| Stage | JNJ | % of rev | KLAC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $25.4B | 100.00% | $4.1B | 100.00% | JNJ ×6.14 |
| Gross profit | $17.3B | 68.12% | $2.6B | 61.85% | JNJ +6.3pp |
| Operating income | $5.8B | 23.01% | $1.9B | 45.01% | KLAC +22.0pp |
| Pre-tax income | $34M | 0.13% | $1.8B | 44.10% | KLAC +44.0pp |
| Net income | $210M | 0.83% | $1.5B | 37.44% | KLAC +36.6pp |
| Stage | JNJ | KLAC | Gap · A − B |
|---|---|---|---|
| Revenue | $25.4B100.00% | $4.1B100.00% | JNJ ×6.14 |
| Gross profit | 68.12%$17.3B | 61.85%$2.6B | JNJ +6.3pp |
| Operating income | 23.01%$5.8B | 45.01%$1.9B | KLAC +22.0pp |
| Pre-tax income | 0.13%$34M | 44.10%$1.8B | KLAC +44.0pp |
| Net income |
| 0.83%$210M |
| 37.44%$1.5B |
| KLAC +36.6pp |
No shared counterparties.